With the world's largest medical device fair opening in Shanghai this week, China's homegrown surgical robots are making global headlines — and attracting international patients
When Dr. Piotr Suwalski sat down at a surgical console in southwest China last month, he wasn't operating on a patient in the same room — or even the same country. Using a Chinese-made surgical robot located more than 7,000 kilometers away in Poland, the Polish doctor successfully completed a complex chest surgery. The patient had minimal bleeding. Recovery was smooth.
It wasn't a demo or a trial. It was one of seven remote operations performed in a single week at the International Remote Robotic Center of West China Hospital of Sichuan University in Chengdu, which opened on March 21, 2026. A Brazilian doctor, Carlos Eduardo Domene, also performed surgery from the Chengdu center on a patient over 10,000 km away in Brazil.
🇨🇳 Why it matters: China's surgical robots have moved well beyond laboratory experiments. The country's medical robotics industry is now exporting technology — and expertise — to hospitals and doctors across Europe, South America, and Southeast Asia. The year 2026 marks a turning point: China released its first-ever national pricing guidelines for surgical robot services, signaling that the industry has matured enough for regulated, widespread adoption.
Those watching the global medical device industry are turning their attention to Shanghai this week. The 93rd China International Medical Equipment Fair (CMEF) — the world's largest medical device trade exhibition — opens April 9-12 at the National Exhibition and Convention Center. Covering over 320,000 square meters and featuring nearly 5,000 brands from more than 20 countries, this year's event is laser-focused on AI, robotics, and international healthcare cooperation. More than 200,000 professional visitors from 150 countries and regions are expected to attend.
China's surgical robot story isn't just about one hospital or one device. It's a systematic build-out spanning research hospitals, university medical centers, and a rapidly growing export pipeline.
West China Hospital in Chengdu has become the flagship of this movement. Founded in 1892, the hospital has invested heavily in robotic surgery since 2015 and now runs one of Asia's most active remote surgery programs. Its International Remote Robotic Center — inaugurated in March 2026 — represents a deliberate strategy shift: instead of bringing patients in for treatment, Chinese hospitals are now sending technology out.
"Compared with traveling to Chengdu for the surgery, patients and their families can now undergo robot-assisted surgery in their hometowns, cutting financial and time burdens by up to 80 percent," said Dr. Wu Hong, liver transplant expert and Vice President of West China Hospital.
Beyond surgery, Chinese researchers are deploying AI across the healthcare spectrum. At this week's CMEF, an AI system capable of "one scan, multiple diagnoses" will make its global debut — simultaneously detecting conditions across different body systems from a single medical image. Other AI diagnostic tools already in clinical use include integrated AI training and inference platforms designed to enhance computing capabilities for hospitals of all sizes.
The numbers tell the story of explosive growth. China's medical equipment exports totaled $45.8 billion in 2025, up 62.4% compared to 2019. Surgical robot exports alone surged 368.1% year-on-year in 2025, according to the China Chamber of Commerce for Import and Export of Medicines and Health Products. The country has shifted from competing on cost to competing on technology and brand strength.
| Factor | China | United States / Europe |
|---|---|---|
| Dominant Technology | Homegrown systems (TINAVI, Yuanhuan, MicroPort, domestically developed robots) | Da Vinci Surgical System (Intuitive Surgical, US) dominates globally |
| Remote Surgery Capability | ✅ Active international remote surgery centers; 7,000-10,000+ km distances proven | ⚠️ Primarily domestic applications; limited international remote surgery infrastructure |
| 2025 Export Growth | +368.1% year-on-year (surgical robots) | Intuitive Surgical expanding in Asia but slower export growth from US |
| Cost per Procedure | Robot-assisted surgery: ¥25,000-80,000 (~$3,500-11,000) — 60-80% less than US equivalent | Da Vinci surgery in US: $3,000-10,000+ per procedure (before hospital fees) |
| Government Support | National pricing guidelines released 2026; Belt and Road Initiative driving exports; AI healthcare policies accelerating adoption | Strong R&D investment; fragmented regulatory landscape across EU member states |
| Clinical Applications | Hepatobiliary, pancreatic, thoracic, colorectal, urology — with growing subspecialty depth | Broad range across specialties; largest experience base in prostate and gynecologic surgery |
| International Patient Access | Direct — international patients can travel to China or access via telemedicine and remote surgery programs | Established medical tourism infrastructure, but higher cost barrier |
Our coordination team can help connect you with top Chinese hospitals offering advanced surgical and medical treatments. Get a free consultation to explore your options.
Get a Free Consultation →